ImmuCell Corporation
✓ Verified ManufacturerAbout
ImmuCell Corporation, headquartered in Portland, Maine, is a pioneering pharmaceutical manufacturing company specializing in innovative colostrum-based products for livestock health. The company operates as the only manufacturer capable of concentrating, purifying, and quantifying specific colostrum antibodies on a commercial scale, delivering immediate immunity solutions to newborn calves. ImmuCell's flagship product, First Defense, is a USDA-accredited colostrum-derived scours preventative that helps protect calves from dangerous digestive infections. The company is also advancing Re-Tain, an intramammary treatment for subclinical mastitis currently nearing FDA approval, representing a significant breakthrough in dairy cow health management. The corporation maintains rigorous compliance with USDA, CFIA, FDA, and OMRI standards, ensuring the highest quality in pharmaceutical manufacturing processes. ImmuCell's mission centers on reducing antibiotic dependence in agriculture while maximizing genetic potential for both dairy and beef producers through science-based disease prevention strategies. With their proprietary colostrum antibody concentration technology and commitment to delivering immediate immunity, ImmuCell Corporation serves as a critical partner for livestock producers seeking effective, regulatory-compliant health solutions. The company's focus on preventing two major agricultural challenges - calf scours and mastitis - positions them as leaders in livestock pharmaceutical innovation and manufacturing excellence.